发明名称 Functional influenza virus-like particles (VLPs)
摘要 The present invention discloses and claims virus like particles (VLPs) that express and/or contains seasonal influenza virus proteins, avian influenza virus proteins and/or influenza virus proteins from viruses with pandemic potential. The invention includes vector constructs comprising said proteins, cells comprising said constructs, formulations and vaccines comprising VLPs of the inventions. The invention also includes methods of making and administrating VLPs to vertebrates, including methods of inducing substantial immunity to either seasonal and avian influenza, or at least one symptom thereof.
申请公布号 US9180180(B2) 申请公布日期 2015.11.10
申请号 US201414149365 申请日期 2014.01.07
申请人 NOVAVAX, INC. 发明人 Smith Gale;Bright Rick;Pushko Peter;Zhang Jinyou;Mahmood Kutub
分类号 A61K39/145;C07K14/005;C12N7/00;C12N15/86;A61K39/12;A61K39/00 主分类号 A61K39/145
代理机构 Cooley, LLP 代理人 Cooley, LLP ;Brown Fraser D.
主权项 1. A vaccine comprising an influenza virus-like particle (VLP) and a pharmaceutically acceptable carrier or excipient, wherein the VLP comprises influenza M1, HA and NA proteins, wherein the vaccine induces substantial immunity to influenza virus infection in an animal susceptible to influenza, wherein the M1 protein is derived from the influenza strain A/Indonesia/5/05, wherein the HA protein is an H7 protein, and wherein the NA protein is an N9 protein.
地址 Gaithersburg MD US